ACTIVE SUBSTANCE / INN

VOLANESORSEN

Brand name(s): Waylivra
EMA LISTED
AUTHORISED
Hyperlipoproteinemia Type I
ACTIVE SUBSTANCE
Volanesorsen
REGULATORS
EMA
SPONSORS / MAH
Akcea Therapeutics Ireland Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
WaylivraAkcea Therapeutics Ireland LimitedAuthorised03/05/2019Hyperlipoproteinemia Type I

FULL INTELLIGENCE ON VOLANESORSEN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →